[1] TING ZHOU. The sphingosine-1-phosphate receptor 1 mediates the atheroprotective effect of eicosapentaenoic acid[J]. Nature metabolism, 2024, 6 8: 1566-1583. DOI:
10.1038/s42255-024-01070-3[2] YOSUKE ISOBE. Comprehensive analysis of the mouse cytochrome P450 family responsible for omega-3 epoxidation of eicosapentaenoic acid.[J]. Scientific Reports, 2018: 7954. DOI:
10.1038/s41598-018-26325-4[3] BIRGIT LAUTERBACH. Cytochrome P450-Dependent Eicosapentaenoic Acid Metabolites Are Novel BK Channel Activators[J]. Hypertension: Journal of the American Heart Association, 2002, 50 1: 609-613. DOI:
10.1161/hy0202.103293[4] RACHEL E WALKER. Effects of inflammation and soluble epoxide hydrolase inhibition on oxylipin composition of very low-density lipoproteins in isolated perfused rat livers.[J]. ACS Applied Bio Materials, 2021: e14480. DOI:
10.14814/phy2.14480[5] REBECA CAIRES. Omega-3 Fatty Acids Modulate TRPV4 Function through Plasma Membrane Remodeling.[J]. Cell reports, 2017, 21 1: 246-258. DOI:
10.1016/j.celrep.2017.09.029[6] DANIEL R MCDOUGLE. Anti-inflammatory ω-3 endocannabinoid epoxides.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2017: E6034-E6043. DOI:
10.1073/pnas.1610325114[7] RYOHEI AOYAGI. Comprehensive analyses of oxidized phospholipids using a measured MS/MS spectra library.[J]. Journal of Lipid Research, 2017, 58 11: 2229-2237. DOI:
10.1194/jlr.d077123